SciMatic
Journals
Thesis Rep
Docs
Products
SciMatic.net
Journament
Journal Manager
Subjects
Thesis
ImProofer
Research Groups
Letter Pad
Conferences
Services
About
SciMatic
Team
Earn With Us
Join Us
Contact Us
EN
English
Türkçe
Español
Português
Pусский
Filipino
Tiếng Việt
हिन्दी
العربية
বাংলা
Deutsch
中文
Login
Keyword Connections
co-delivery
Journals
5
1
Nanomaterials (Basel, Switzerland)
2
colloids and surfaces b, biointerfaces
3
Biomacromolecules
4
bioconjugate chemistry
5
drug development and industrial pharmacy
Research Groups
0
No Research Group Connected
Bibliographies
25
1
Design and synthesis of mixed micellar system for enhanced anticancer efficacy of Paclitaxel through its co-delivery with Naringin.
2
Galactosylated Liposomes for Targeted Co-Delivery of Doxorubicin/Vimentin siRNA to Hepatocellular Carcinoma.
3
Galactose-based Thermosensitive Nanogels for Targeted Drug Delivery of Iodoazomycin Arabinofuranoside (IAZA) for Theranostic Management of Hypoxic Hepatocellular Carcinoma.
4
Ligand-directed reduction-sensitive shell-sheddable biodegradable micelles actively deliver doxorubicin into the nuclei of target cancer cells.
5
Targeted doxorubicin delivery by chitosan-galactosylated modified polymer microbubbles to hepatocarcinoma cells.
6
Design and synthesis of bis-biotin-containing reagents for applications utilizing monoclonal antibody-based pretargeting systems with streptavidin mutants.
7
co-delivery nanoparticles with characteristics of intracellular precision release drugs for overcoming multidrug resistance
8
recent advances in nanoformulations for co-delivery of curcumin and chemotherapeutic drugs
9
co-delivery of aurora-a inhibitor xy-4 and bcl-xl sirna enhances antitumor efficacy for melanoma therapy
10
Transferrin-Modified Nanoliposome Codelivery Strategies for Enhancing the Cancer Therapy
11
Nuclear-targeted p53 and DOX co-delivery of chitosan derivatives for cancer therapy in vitro and in vivo.
12
Cancer cell membrane cloaking nanoparticles for targeted co-delivery of doxorubicin and PD-L1 siRNA.
13
Anti-GPC3 Antibody Tagged Cationic Switchable Lipid-Based Nanoparticles for the Co-Delivery of Anti-miRNA27a And Sorafenib in Liver Cancers.
14
Bacterial magnetosomes-based nanocarriers for co-delivery of cancer therapeutics in vitro
15
Co-delivery of free vancomycin and transcription factor decoy-nanostructured lipid carriers can enhance inhibition of methicillin resistant Staphylococcus aureus (MRSA).
16
Core-Shell Biopolymer Nanoparticles for Co-Delivery of Curcumin and Piperine: Sequential Electrostatic Deposition of Hyaluronic Acid and Chitosan Shells on the Zein Core.
17
Co-delivery of curcumin and piperine in zein-carrageenan core-shell nanoparticles: Formation, structure, stability and in vitro gastrointestinal digestion
18
Co-delivery of doxorubicin and TRAIL plasmid by modified PAMAM dendrimer in colon cancer cells, and evaluation.
19
Co-delivery of erlotinib and doxorubicin by MoS<inf>2</inf> nanosheets for synergetic photothermal chemotherapy of cancer
20
Doxorubicin/Cisplatin-Loaded Superparamagnetic Nanoparticles As A Stimuli-Responsive Co-Delivery System For Chemo-Photothermal Therapy.
21
Doxorubicin/Cisplatin-Loaded Superparamagnetic Nanoparticles As A Stimuli-Responsive Co-Delivery System For Chemo-Photothermal Therapy
22
Enhanced combination therapy effect on paclitaxel-resistant carcinoma by chloroquine co-delivery via liposomes
23
Modulating chitosan-PLGA nanoparticle properties to design a co-delivery platform for glioblastoma therapy intended for nose-to-brain route.
24
sustained co-delivery of bio and igf-1 by a novel hybrid hydrogel system to stimulate endogenous cardiac repair in myocardial infarcted rat hearts
25
Correction to: Nano-drug co-delivery system of natural active ingredients and chemotherapy drugs for cancer treatment: a review (Drug Delivery, (2022), 29, 1, (2130-2161), 10.1080/10717544.2022.2094498)